Drug

Anifrolumab-fnia

33 flagged reaction(s) · 525 total co-reports · max PRR 50.8

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Systemic Lupus Erythematosus	149	50.8	55.5	signal
2	Insurance Issue	29	23.5	23.9	signal
3	Pericarditis	32	23.1	23.5	signal
4	Herpes Zoster	66	13.8	14.3	signal
5	Proteinuria	20	12.8	12.9	signal
6	Brain Fog	13	10.7	10.8	signal
7	Vasculitis	10	10.3	10.4	signal
8	Infusion Site Pain	9	8.5	8.5	signal
9	Pharyngeal Swelling	6	7.5	7.6	signal
10	Myocarditis	7	7.4	7.5	signal
11	Immune System Disorder	7	6.4	6.4	signal
12	Drug Effect Less Than Expected	7	6.0	6.0	signal
13	Hepatic Cytolysis	6	5.9	5.9	signal
14	Photosensitivity Reaction	8	5.8	5.9	signal
15	Hyperbilirubinaemia	5	5.8	5.8	signal
16	Infusion Related Reaction	30	5.5	5.5	signal
17	Illness	44	5.3	5.4	signal
18	Bronchospasm	6	5.0	5.1	signal
19	Paraesthesia Oral	6	5.0	5.0	signal
20	Tuberculosis	5	4.7	4.7	signal
21	Lip Swelling	12	4.3	4.4	signal
22	Oral Herpes	7	4.3	4.3	signal
23	Skin Reaction	5	4.3	4.3	signal
24	Increased Tendency To Bruise	3	3.9	3.9	no signal
25	Therapy Change	3	3.7	3.7	no signal
26	Pneumocystis Jirovecii Pneumonia	3	3.6	3.6	no signal
27	Poor Venous Access	3	3.5	3.5	no signal
28	Blindness Unilateral	4	3.4	3.4	signal
29	Complication Associated With Device	3	2.7	2.7	no signal
30	Uveitis	3	2.7	2.7	no signal
31	Synovitis	4	2.7	2.7	no signal
32	Therapeutic Response Shortened	7	2.6	2.6	signal
33	Wrong Technique In Device Usage Process	3	0.8	0.8	no signal